Additionally, as illustrated in Table S2, higher RAC1 expression in tumors was significantly associated with larger tumor sizes (P < 0.05), lymph node metastasis (P = 0.001), and poorer clinical stages (P < 0.001). The gene discussed is RAC1; the disease is neoplasm.